Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132705) titled 'Application of Quantitative Third Harmonic Generation Microscopy imaging in the pathological diagnosis of orbital tumors' on Sept. 17.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Tianjin Medical University Eye Hospital
Condition:
Meibomian gland carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-22
Target Sample Size: Observation group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340854
Published by HT Digital Content Services with permission from Health Daily Digest....